BCWORLD PHARM. Co., Ltd.

KOSDAQ 200780.KQ

BCWORLD PHARM. Co., Ltd. EBIT for the year ending December 31, 2023: USD 4.95 M

BCWORLD PHARM. Co., Ltd. EBIT is USD 4.95 M for the year ending December 31, 2023, a 175.97% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

BCWORLD PHARM. Co., Ltd. EBIT for the year ending December 31, 2022 was USD 1.79 M, a 379.24% change year over year.
BCWORLD PHARM. Co., Ltd. EBIT for the year ending December 31, 2021 was USD -641.82 K, a -69.79% change year over year.
BCWORLD PHARM. Co., Ltd. EBIT for the year ending December 31, 2020 was USD -378.02 K, a 64.25% change year over year.
BCWORLD PHARM. Co., Ltd. EBIT for the year ending December 31, 2019 was USD -1.06 M, a -120.67% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

KOSDAQ: 200780.KQ

BCWORLD PHARM. Co., Ltd.

CEO	Mr. Sung-Han Hong
IPO Date	Dec. 15, 2014
Location	South Korea
Headquarters	22 Geumto-ro 40beon-gil
Employees	284
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberculosis drugs, anti-emetic, antiviral drugs, antibiotic, anti-malignant tumor drugs, antifungal agent, antihistamines, antidote, and antipyretic/analgesic/anti-inflammatory. BCWORLD PHARM. Co., Ltd. was founded in 1980 and is headquartered in Seongnam-si, South Korea.

Key trends

Past 5 years